comparemela.com

Latest Breaking News On - Viracta therapeutics inc - Page 1 : comparemela.com

Day One Announces Sale of Priority Review Voucher for $108 Million

Day One Announces Sale of Priority Review Voucher for $108 Million
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

Day One Announces Sale of Priority Review Voucher for $108

Day One Announces Sale of Priority Review Voucher for $108
globenewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from globenewswire.com Daily Mail and Mail on Sunday newspapers.

Viracta Therapeutics (NASDAQ:VIRX) Price Target Cut to $11 00

Viracta Therapeutics (NASDAQ:VIRX – Free Report) had its price target decreased by Oppenheimer from $13.00 to $11.00 in a report released on Thursday morning, Benzinga reports. Oppenheimer currently has an outperform rating on the stock. Separately, HC Wainwright reissued a buy rating and issued a $4.00 price objective on shares of Viracta Therapeutics in a […]

Viracta Therapeutics (NASDAQ:VIRX) PT Lowered to $11 00 at Oppenheimer

Viracta Therapeutics (NASDAQ:VIRX – Free Report) had its price target lowered by Oppenheimer from $13.00 to $11.00 in a research note released on Thursday morning, Benzinga reports. The brokerage currently has an outperform rating on the stock. Separately, HC Wainwright reaffirmed a buy rating and set a $4.00 target price on shares of Viracta Therapeutics […]

Viracta Therapeutics Announces New Employment Inducement Grants

Viracta Therapeutics Announces New Employment Inducement Grants
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.